Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.
Phase 1/2 trial design - Population: 37 patients with relapsed/refractory Ewing sarcoma. - Regimen: Trabectedin as a...
Phase 1/2 trial design - Population: 37 patients with relapsed/refractory Ewing sarcoma. - Regimen: Trabectedin as a...
This publication reports on the Phase II ROME trial, a randomized study assessing whether treatment selection guided by...
This publication is a narrative review examining how tumor location within the rectum should influence the use and inten...
This study evaluated FGFR2b protein expression in a large real‑world cohort of 1331 patients with locally advanced or...
This study reports real-world implementation of routine paired tumor–normal whole-genome sequencing (WGS) for solid tu...
This study describes UPATHLN, a pan-cancer AI system for detecting lymph node metastases on pathology slides, with a spe...